Queen's University at Kingston

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1841-10-16

Employees: 1K

Market Cap: -

Website: http://www.queensu.ca

Clinical Trials

Connecting Families

Not Applicable

Recruiting

Conditions: Primary Care
Poverty
Intervention

Interventions: Other: Usual Care
Other: Community Support Worker

First Posted Date: 2021-10-25

Last Posted Date: 2023-11-24

Lead Sponsor: Queen's University

Target Recruit Count: 80

Registration Number: NCT05091957

Locations: 🇨🇦
Queen's Family Health Team, Kingston, Ontario, Canada

Spinal Cord Injury Mental Health Functional Outcomes Improved by Mindfulness

Not Applicable

Completed

Conditions: Spinal Cord Injuries
Mindfulness Meditation
Mental Health Wellness 1

Interventions: Behavioral: Mindfulness meditation (MM)

First Posted Date: 2021-07-22

Last Posted Date: 2023-03-29

Lead Sponsor: Queen's University

Target Recruit Count: 10

Registration Number: NCT04972773

Locations: 🇨🇦
Providence Care Hospital, Kingston, Ont, Canada

Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer

Phase 2

Recruiting

Conditions: Ovarian Cancer

Interventions: Drug: Durvalumab
Drug: To be determined
Drug: BA3011
Drug: BA3021

First Posted Date: 2021-06-08

Last Posted Date: 2024-07-18

Lead Sponsor: Canadian Cancer Trials Group

Target Recruit Count: 60

Registration Number: NCT04918186

Locations: 🇨🇦
The Jewish General Hospital, Montreal, Quebec, Canada
🇨🇦
CHUM-Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada
🇨🇦
Odette Cancer Centre, Toronto, Ontario, Canada

and more 4 locations

Patient Satisfaction and Visual Function Following Implantation of Trifocals or Extended Range of Vision Intraocular Lenses

Conditions: Cataract

First Posted Date: 2021-05-25

Last Posted Date: 2022-02-04

Lead Sponsor: Queen's University

Target Recruit Count: 480

Registration Number: NCT04900662

Locations: 🇨🇦
Kensington Eye Institute, Toronto, Ontario, Canada

Combined Ketamine and eCBT Intervention for PTSD

Phase 2

Conditions: Post-Traumatic Stress Disorder

Interventions: Drug: Ketamine
Behavioral: Online Trauma-Focused Cognitive Behavioural Therapy

First Posted Date: 2021-02-25

Last Posted Date: 2022-08-11

Lead Sponsor: Queen's University

Target Recruit Count: 16

Registration Number: NCT04771767

Locations: 🇨🇦
Queen's University, Kingston, Ontario, Canada

177 LuPSMA-617 vs Docetaxel in Metastatic Castration Resistant and PSMA-Positive Prostate Cancer

Phase 2

Active, not recruiting

Conditions: Prostate Cancer

Interventions: Drug: 177Lu-PSMA-617
Drug: Docetaxel

First Posted Date: 2020-12-11

Last Posted Date: 2024-08-29

Lead Sponsor: Canadian Cancer Trials Group

Target Recruit Count: 200

Registration Number: NCT04663997

Locations: 🇨🇦
Tom Baker Cancer Centre, Calgary, Alberta, Canada
🇨🇦
BCCA - Vancouver Cancer Centre, Vancouver, British Columbia, Canada
🇨🇦
University Health Network, Toronto, Ontario, Canada

and more 7 locations

Fulvestrant and Ipatasertib for Advanced HER-2 Negative and Estrogen Receptor Positive (ER+) Breast Cancer Following Progression on First Line CDK 4/6 Inhibitor and Aromatase Inhibitor

Phase 3

Active, not recruiting

Conditions: Breast Cancer

Interventions: Drug: Ipatasertib
Drug: Fulvestrant
Other: Placebo

First Posted Date: 2020-12-02

Last Posted Date: 2024-07-31

Lead Sponsor: Canadian Cancer Trials Group

Target Recruit Count: 250

Registration Number: NCT04650581

Locations: 🇨🇦
QEII Health Sciences Centre, Halifax, Nova Scotia, Canada
🇨🇦
Centre Integre de Sante et de Services Sociaux, Greenfield Park, Quebec, Canada
🇨🇦
CHUM-Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada

and more 36 locations

Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure

Phase 3

Active, not recruiting

Conditions: Covid-19
Cancer

Interventions: Other: Observation
Biological: IMM-101

First Posted Date: 2020-06-22

Last Posted Date: 2024-07-31

Lead Sponsor: Canadian Cancer Trials Group

Target Recruit Count: 195

Registration Number: NCT04442048

Locations: 🇨🇦
Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada
🇨🇦
London Regional Cancer Program, London, Ontario, Canada
🇨🇦
Odette Cancer Centre, Toronto, Ontario, Canada

and more 5 locations

Determining the Effectiveness of a New Phototherapy Treatment for the Knee Osteoarthritis

Not Applicable

Completed

Conditions: Osteoarthritis, Knee

Interventions: Device: High Intensity Physio Light Therapy (HIPL Therapy™)
Behavioral: Aerobic Exercise
Behavioral: Education
Behavioral: Resistance Exercise
Device: Placebo Physio Light Therapy (HIPL Therapy™)

First Posted Date: 2020-01-21

Last Posted Date: 2020-01-21

Lead Sponsor: Queen's University

Target Recruit Count: 20

Registration Number: NCT04234685

Locations: 🇨🇦
Queen's University, Kingston, Ontario, Canada

Emotion and Symptom-Focused Engagement Trial for Individuals With Acute Leukemia

Not Applicable

Recruiting

Conditions: Acute Leukemia

Interventions: Behavioral: EASE-psy
Other: Usual Care

First Posted Date: 2020-01-13

Last Posted Date: 2024-12-11

Lead Sponsor: Canadian Cancer Trials Group

Target Recruit Count: 266

Registration Number: NCT04224974

Locations: 🇨🇦
Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada
🇨🇦
Kingston Health Sciences Centre, Kingston, Ontario, Canada
🇨🇦
Ottawa Hospital Research Institute, Ottawa, Ontario, Canada

and more 2 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy